Home › Funds › NORRIS PERNE & FRENCH LLP/MI › JNJ

NORRIS PERNE & FRENCH LLP/MI position in JNJ

JOHNSON JOHNSON · Health Care

NORRIS PERNE & FRENCH LLP/MI reported holding 82,726 shares of JNJ (JOHNSON JOHNSON) in its Q2 2026 13F filing — a position valued at US$21.0M, representing 1.43% of its reported portfolio and ranking #13 among its reported holdings. NORRIS PERNE & FRENCH LLP/MI has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)82.73K sh
Reported value held$21.01M
Portfolio Weight1.43%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How NORRIS PERNE & FRENCH LLP/MI's JNJ position evolved

NORRIS PERNE & FRENCH LLP/MI first disclosed a stake in JNJ in Q3 2023 at 98,968 shares (US$15.4M). The position peaked in Q4 2025 at 186,600 shares, worth US$38.6M. Across 12 filings, NORRIS PERNE & FRENCH LLP/MI increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 82,726 shares valued at US$21.0M. Notable position changes include a 44% increase in Q2 2024 (shares rose 11% over the following quarter), a 56% trim in Q1 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 98.97K $15.41M New
Q4 2023 103.12K $16.16M Add
Q1 2024 107.33K $16.98M Add
Q2 2024 154.20K $22.54M Add
Q3 2024 187.22K $30.34M Add
Q4 2024 187.34K $27.09M Hold
Q1 2025 187.40K $31.08M Hold
Q2 2025 191.64K $29.27M Add
Q3 2025 191.87K $35.58M Hold
Q4 2025 186.60K $38.62M Reduce
Q1 2026 82.66K $20.20M Reduce
Q2 2026 82.73K $21.01M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has NORRIS PERNE & FRENCH LLP/MI held JNJ?

NORRIS PERNE & FRENCH LLP/MI has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is NORRIS PERNE & FRENCH LLP/MI's current position in JNJ?

As of Q2 2026, NORRIS PERNE & FRENCH LLP/MI holds 82.73K shares of JNJ (JOHNSON JOHNSON), valued at $21.01M, representing 1.43% of its reported portfolio and ranking #13.

Has NORRIS PERNE & FRENCH LLP/MI been buying or selling JNJ?

In the latest 13F filing (Q2 2026), NORRIS PERNE & FRENCH LLP/MI held unchanged its position in JNJ. The position peaked in Q4 2025 at 186.60K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.